Expiration date: 03/2025
The composition and form of issue:
Lozenges, 1 tablet cibtains:
the bacterial lysates mixture (dry matter): group A Streptococcus pyogenes, Enterococcus faecalis, Enterococcus faecium, Streptococcus sanguis, Staphylococcus aureus subsp. aureus, Klebsiella pneumoniae subsp. pneumoniae, Corynebacterium pseudodiphtheriticum, Fusobacterium nucleatum subsp. nucleatum, Candida albicans, Lactobacillus acidophilus, Lactobacillus fermentum, Lactobacillus helveticus, Lactobacillus delbrueckii subsp. lactis 50 mg
auxiliary substances: lactose, mannitol, glycine, povidone, sodium sodium saccharin sodium bicarbonate desoxycholate anhydrous citric acid powder mint magnesium stearate sodium thimerosal (preservative) — no more than 12.5 mcg/table.
in blistere 8 PCs. in cardboard box 5 blisters.
Description pharmaceutical form:
White or almost white tablets PLANO-cylindrical shape with a smooth shiny surface with beveled edges without pores.
Feature:
Polyvalent antigenic complex mixture of bacterial lysates, which is consistent with the agents most frequently causing inflammation in the mouth and throat.
Description pharmacological action:
Immunostimulatory preparation of bacterial origin for local use in dentistry and otolaryngology. Activates phagocytosis, increases the amount of immunocompetent cells, enhances the production of lysozyme, interferon and secretory immunoglobulin A in saliva.
Indications:
Treatment and/or prevention of:
- superficial and deep periodontal disease, periodontitis, stomatitis, glossitis, aphthous stomatitis
- inflammatory and infectious diseases of the oral cavity and pharynx
- erythematous and ulcerative gingivitis
- dysbacteriosis of the oral cavity
- pharyngitis
- chronic tonsillitis
- ulceration caused by dentures
- infection after tooth extraction, implantation of artificial dental roots
- preoperative preparation for tonsillectomy
- the postoperative period after tonsillectomy.
Contraindications:
increased individual sensitivity to the drug or its components
children up to age 3 years.
Application of pregnancy and breast-feeding:
Information about the use of Imudon in pregnant women insufficient. Relevant data from animal studies and epidemiological studies do not exist.
It is not recommended to take Imudon during pregnancy or lactation.
Side effects:
Rare:
- gastrointestinal: nausea, vomiting, abdominal pain
- allergic reactions: rash, urticaria, angioedema.
Drug interactions:
Imudon can be used with drugs other groups.
Method of application and dose:
Inside.
Adults and adolescents over 14 years
In acute inflammatory diseases of the mouth and throat, and exacerbation of chronic diseases: — 8 table. a day. Pills resolves (without chewing) in the mouth at intervals of 1 h. the Average duration of treatment is 10 days.
For the prevention of chronic inflammatory diseases of the oral cavity and pharynx: for 6 tab. a day. Pills resolves (without chewing) in the mouth every 2 hours course Duration — 20 days.
Children from 3 to 14 years
In the treatment of acute and exacerbation of chronic inflammatory diseases of the oral cavity and pharynx, as well as for the prevention of: 6 table. a day. Pills resolves (without chewing) in the mouth at intervals of 2 h. the Duration of treatment in acute diseases — 10 days, for the prevention of chronic — 20 days.
It is recommended to carry out preventive courses admission Imudona 3-4 times a year.
Overdose:
Overdoses of the drug Imudon not described.
Special instructions:
Children 3 to 6 years to resolve tablets in the oral cavity under the supervision of an adult!
If necessary rinse your mouth with it is possible not earlier than through 1 h after administration (not to reduce the therapeutic activity of the drug). In appointing the drug to patients who observe salt-free or malasaeva diet, be aware that 1 table. Imudona contains 15 mg of sodium.
There is no evidence of the need for any restrictions on activities associated with driving or operating other mechanisms during treatment.
